185 related articles for article (PubMed ID: 10560527)
1. DNA ploidy and nuclear morphometry for the classification of dysplastic nevi.
Williams RA; Baak JP; Meijer GA; Charlton IG
Anal Quant Cytol Histol; 1999 Oct; 21(5):437-44. PubMed ID: 10560527
[TBL] [Abstract][Full Text] [Related]
2. Differentiating benign nevi from malignant melanoma using DNA microdensitometry and karyometry and maturation: a zonal comparison, correlation and multivariate analysis.
Li LX; Crotty KA; Palmer AA; Kril JJ; Stankovic R; Scolyer RA; McCarthy SW
Anal Quant Cytol Histol; 2002 Aug; 24(4):234-43. PubMed ID: 12199325
[TBL] [Abstract][Full Text] [Related]
3. Image analysis cytometry of dysplastic nevi.
Fleming MG; Wied GL; Dytch HE
J Invest Dermatol; 1990 Sep; 95(3):287-91. PubMed ID: 2200831
[TBL] [Abstract][Full Text] [Related]
4. Morphometric, DNA, and proliferating cell nuclear antigen measurements in benign melanocytic lesions and cutaneous malignant melanoma.
Björnhagen V; Bonfoco E; Brahme EM; Lindholm J; Auer G
Am J Dermatopathol; 1994 Dec; 16(6):615-23. PubMed ID: 7864299
[TBL] [Abstract][Full Text] [Related]
5. Differentiation between malignant melanomas and benign melanocytic nevi by computerized DNA cytometry of imprint specimens.
Stolz W; Vogt T; Landthaler M; Hempfer S; Bingler P; Abmayr W
J Cutan Pathol; 1994 Feb; 21(1):7-15. PubMed ID: 8188937
[TBL] [Abstract][Full Text] [Related]
6. Discrimination between benign and malignant melanocytic skin lesions by multivariate analysis, quantitative S-100 immunohistochemistry, nuclear morphometry and DNA cytometry.
Williams RA; Rode J; Baak JP; Charlton IG
Anal Quant Cytol Histol; 1999 Aug; 21(4):353-7. PubMed ID: 10560514
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of DNA ploidy in dysplastic and Spitz nevi by flow cytometry.
Winokur TS; Palazzo JP; Johnson WC; Duray PH
J Cutan Pathol; 1990 Dec; 17(6):342-7. PubMed ID: 2074280
[TBL] [Abstract][Full Text] [Related]
8. Dysplastic nevi.
Farber MJ; Heilman ER; Friedman RJ
Dermatol Clin; 2012 Jul; 30(3):389-404. PubMed ID: 22800547
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
[TBL] [Abstract][Full Text] [Related]
10. Comparison of image analysis with flow cytometry for DNA content analysis in pigmented lesions of the skin.
Sangueza OP; Hyder DM; White CR; Pallander J; Perkins M; Remple N; Bakke A
Anal Quant Cytol Histol; 1992 Feb; 14(1):55-9. PubMed ID: 1558616
[TBL] [Abstract][Full Text] [Related]
11. Analysis of melanocytic lesions by DNA image cytometry.
Schmidt B; Weinberg DS; Hollister K; Barnhill RL
Cancer; 1994 Jun; 73(12):2971-7. PubMed ID: 8199994
[TBL] [Abstract][Full Text] [Related]
12. AgNORs in benign, dysplastic, and malignant melanocytic skin lesions.
Howat AJ; Wright AL; Cotton DW; Reeve S
Am J Dermatopathol; 1990 Apr; 12(2):156-61. PubMed ID: 2331050
[TBL] [Abstract][Full Text] [Related]
13. Consumption of the epidermis: a criterion in the differential diagnosis of melanoma and dysplastic nevi that is associated with increasing breslow depth and ulceration.
Walters RF; Groben PA; Busam K; Millikan RC; Rabinovitz H; Cognetta A; Mihm MC; Prieto VG; Googe PB; King R; Moore DT; Woosley J; Thomas NE
Am J Dermatopathol; 2007 Dec; 29(6):527-33. PubMed ID: 18032946
[TBL] [Abstract][Full Text] [Related]
14. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 and D3 expression in melanocytic skin lesions.
Alekseenko A; Wojas-Pelc A; Lis GJ; Furgał-Borzych A; Surówka G; Litwin JA
Arch Dermatol Res; 2010 Sep; 302(7):545-50. PubMed ID: 20496072
[TBL] [Abstract][Full Text] [Related]
16. Influence of section thickness, mean nuclear diameter and nuclear crowding on DNA ploidy in histologic sections of melanocytic skin lesions.
Williams RA; Baak JP; Meijer GA; Charlton IG
Anal Quant Cytol Histol; 1999 Oct; 21(5):413-24. PubMed ID: 10560524
[TBL] [Abstract][Full Text] [Related]
17. Dysplastic Nevi: Morphology and Molecular and the Controversies In-between.
Wiedemeyer K; Hartschuh W; Brenn T
Surg Pathol Clin; 2021 Jun; 14(2):341-357. PubMed ID: 34023110
[TBL] [Abstract][Full Text] [Related]
18. Dysplastic melanocytic nevi of the lower leg: sex- and site-specific histopathology.
Coras B; Landthaler M; Stolz W; Vogt T
Am J Dermatopathol; 2010 Aug; 32(6):599-602. PubMed ID: 20534984
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of proliferation indices and ploidy in dysplastic naevi and malignant melanomas using flow cytometry.
Slater SD; Cook MG; Fisher C; Wright NA; Foster CS
Histopathology; 1991 Oct; 19(4):337-44. PubMed ID: 1937413
[TBL] [Abstract][Full Text] [Related]
20. [Characteristics of the statistical data processing in the computed ploidometric diagnosis of melanocytic tumors of the skin].
Chervonnaia LV; Avtandilov GG; Olimpieva SP
Klin Lab Diagn; 2005 Aug; (8):45-7. PubMed ID: 16218340
[No Abstract] [Full Text] [Related]
[Next] [New Search]
